Effect of Lymphatic Mapping on Diagnosis and Treatment of Patients with T1a, T1b Favorable Breast Cancer

Annals of Surgery

Volumn 237, Issue 6, 2003, Pages 838-843

  Jakub, James W ^b,c   Ebert, Mark D ^a   Diaz, Nils M ^a   Cantor, Alan ^a   Reintgen, Douglas S ^b   Dupont, Elisabeth L ^a   Shons, Alan R ^a   Cox, Charles E ^a   Bland, Kirby I ^c   McMasters, Kelly M ^c   Copeland III, Edward M ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b Lakeland Regional Cancer Center   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHATIC MAPPING; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE; ARTICLE; BREAST TUMOR; CANCER STAGING; PAGET NIPPLE DISEASE; PATHOLOGY; PREDICTION AND FORECASTING; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SENTINEL LYMPH NODE BIOPSY;

EID: 85047693895     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SLA.0000071564.27229.A9     Document Type: Conference Paper

References (14)

1. Barth A, Craig PH, Silverstein MJ. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma. Cancer. 1997;79:1918-1922.
2. Chadha M, Chabon AB, Friedmann P, et al. Predictors of axillary lymph node metastases in patients with T1 breast cancer: A multivariate analysis. Cancer. 1994;73:350-353.
3. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg. 2001;25:767-772.
4. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-1822.
5. Bass SS, Cox CE, Salud CJ, et al. The effects of postinjection massage on the sensitivity of lymphatic mapping in breast cancer. J Am Coll Surg. 2001;192:9-16.
6. Burak WE Jr, Owens KE, Tighe MB, et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg. 2000;135:700-703.
7. Lee CH, Carter D, Philpotts LE, et al. Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology. 2000;217:466-470.
8. Jackman RJ, Nowels KW, Rodriguez-Soto J, et al. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology. 1999;210:799-805.
9. Darling ML, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol. 2000;175:1341-1346.
10. Bass SS, Dauway E, Mahatme A, et al. Lymphatic mapping with sentinel lymph node biopsy in patients with breast cancers <1 centimeter (T1A-T1B). Am Surg. 1999;65:857-862.
11. Pendas S, Dauway E, Cox CE, et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg. 1999;65:500-506.
12. Chu KU, Turner RR, Hansen NM, et al. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg. 1999;229:536-541.
13. Sabel MS, Zhang P, Barnwell JM, et al. Accuracy of sentinel node biopsy in predicting nodal status in patients with breast carcinoma. J Surg Oncol. 2001;77:243-246.
14. Turner RR, Giuliano AE, Hoon DS, et al. Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg. 2001;25:798-805.